| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 2.9K | 9.2% |
| Total Income | 2.9K | 9.2% |
| Expenditure | 2.5K | 8.2% |
| PBT | 334.00 | 21.0% |
| Net Profit | 252.00 | 14.6% |
| OPM | 13.78% | 0.73pp |
| NPM | 8.71% | 0.41pp |
| EPS | 2.27 | 15.2% |
Quest Diagnostics Reports Q1 2026 Revenue of $2.90 Billion, Up 9.2%
21 Apr 2026 · 21 Apr, 4:18 pm
Summary
Quest Diagnostics reported first quarter 2026 revenues of $2.90 billion, a 9.2% increase compared to the previous year. Diluted earnings per share grew by 15.5% to $2.24, while adjusted diluted EPS increased by 13.1% to $2.50. The company is raising its revenue and EPS guidance for the full year 2026, expecting reported diluted EPS between $9.58 and $9.78 and adjusted diluted EPS between $10.63 and $10.83. Management cited disciplined execution and innovative diagnostic solutions as drivers of the robust first quarter performance.
Key Highlights
- 1
First quarter revenues reached $2.90 billion, reflecting a 9.2% increase from 2025, with 9.0% organic revenue growth.
- 2
Reported diluted earnings per share for the first quarter were $2.24, up 15.5% from 2025.
- 3
Adjusted diluted earnings per share for the first quarter increased by 13.1% to $2.50 compared to 2025.
- 4
The company now expects full year 2026 reported diluted EPS to be between $9.58 and $9.78.
- 5
Full year 2026 adjusted diluted EPS is projected to be between $10.63 and $10.83.
- 6
Diagnostic Information Services revenues increased by 9.4% to $2.83 billion.
Management Comments
Jim Davis
Our more than 9% revenue growth, almost entirely organic, and approximately 13% adjusted diluted earnings per share growth reflect our team’s disciplined execution of our strategy to deliver innovative diagnostic solutions for our customers’ evolving needs. We are raising our revenue and EPS guidance for the year, given our robust first quarter performance and continued strategic focus.
Informational and educational content only. Not investment advice.